secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0000950170-24-127673
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA raises CEO & CFO base salaries; grants options for 1.56M shares at $4.94
-------------------------------------------------------------------------------

- CEO Bianco base salary increased to $499,000; CFO Dearborn to $375,000, effective Jan 1, 2025.
- Bianco granted options for 1,065,990 shares; Dearborn for 489,848 shares, exercise price $4.94.
- Options vest in 1/3 annual installments over 3 years, 10-year term, under 2024 Equity Incentive Plan.
- Compensation Committee set salaries at ~80% of peer group 50th percentile.
- Approved form of stock option agreement, filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024127673/0000950170-24-127673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024127673/hura-20241115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-127673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer